Literature DB >> 12879479

Racial differences in survival after diagnosis with primary malignant brain tumor.

Jill S Barnholtz-Sloan1, Andrew E Sloan, Ann G Schwartz.   

Abstract

BACKGROUND: Previous studies have shown that the overall incidence of primary malignant brain tumor is greatest in Caucasians, although survival is better in African Americans. The objective of this study was to examine racial differences in survival after diagnosis with primary malignant brain tumor in a population-based sample of patients while adjusting for prognostic variables that differ by race.
METHODS: The authors analyzed 21,493 patients (20,493 Caucasians and 1000 African Americans) who were diagnosed with primary malignant brain tumors from 1973 to 1997 (with follow-up through 1999) from the population-based Surveillance, Epidemiology, and End Results (SEER) Program. Chi-square tests were used to determine statistical significance of prognostic variables and race (using two-sided P values). Kaplan-Meier and Cox proportional hazards models were used to assess survival differences by race.
RESULTS: The univariable model for race showed no survival difference by race. The multivariable model demonstrated that African American patients were at a 13% increased risk of death from any cause compared with Caucasian patients. The racial difference was explained further by an interaction between race and surgery type in which there was an increased risk of death for African American patients who underwent subtotal resections or surgery not otherwise specified compared with Caucasian patients who underwent the same procedures.
CONCLUSIONS: There was a significant difference in the risk of death due to any cause for Caucasian patients and African American patients who were diagnosed with first primary brain tumors. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11534

Entities:  

Mesh:

Year:  2003        PMID: 12879479     DOI: 10.1002/cncr.11534

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  A qualitative assessment of the supportive care and resource needs of patients undergoing craniotomy for benign brain tumours.

Authors:  Janice Wong; Daniel Mendelsohn; Joyce Nyhof-Young; Mark Bernstein
Journal:  Support Care Cancer       Date:  2010-10-27       Impact factor: 3.603

2.  The survival of patients with high grade glioma from different ethnic groups in South East England.

Authors:  T Ratneswaren; R M Jack; D Tataru; E A Davies
Journal:  J Neurooncol       Date:  2014-08-26       Impact factor: 4.130

3.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

4.  Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014.

Authors:  Haley Gittleman; Alexander Boscia; Quinn T Ostrom; Gabrielle Truitt; Yi Fritz; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-11-09       Impact factor: 12.300

Review 5.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.

Authors:  Jacob Y Shin; Aidnag Z Diaz
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

Review 7.  The role of unconscious bias in surgical safety and outcomes.

Authors:  Heena P Santry; Sherry M Wren
Journal:  Surg Clin North Am       Date:  2011-12-06       Impact factor: 2.741

8.  Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.

Authors:  David A Siegel; Jun Li; Helen Ding; Simple D Singh; Jessica B King; Lori A Pollack
Journal:  Pediatr Blood Cancer       Date:  2018-10-23       Impact factor: 3.167

9.  Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism.

Authors:  Meijing Wu; Jason Miska; Ting Xiao; Peng Zhang; J Robert Kane; Irina V Balyasnikova; James P Chandler; Craig M Horbinski; Maciej S Lesniak
Journal:  J Neurooncol       Date:  2019-01-31       Impact factor: 4.130

10.  Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.

Authors:  Ryan Rhome; Rebecca Fisher; Adília Hormigo; Rahul R Parikh
Journal:  J Neurooncol       Date:  2016-03-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.